盐酸三甲氧苯酰胺结构式
|
常用名 | 盐酸三甲氧苯酰胺 | 英文名 | Trimethobenzamide hydrochloride |
|---|---|---|---|---|
| CAS号 | 554-92-7 | 分子量 | 424.91800 | |
| 密度 | 1.131g/cm3 | 沸点 | 506.9ºC at 760mmHg | |
| 分子式 | C21H29ClN2O5 | 熔点 | 187.5-190° | |
| MSDS | N/A | 闪点 | N/A | |
| 符号 |
GHS07, GHS08 |
信号词 | Danger |
盐酸三甲氧苯酰胺用途Trimethobenzamide hydrochloride 是多巴胺 D2 受体阻断剂,可用作预防恶心和呕吐的止吐剂。 |
| 中文名 | 盐酸三甲氧苯酰胺 |
|---|---|
| 英文名 | N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide,hydrochloride |
| 中文别名 | 盐酸曲美苄胺 |
| 英文别名 | 更多 |
| 描述 | Trimethobenzamide hydrochloride 是多巴胺 D2 受体阻断剂,可用作预防恶心和呕吐的止吐剂。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
D2 receptor[1] |
| 体外研究 | Trimethobenzamide是一种(非吩噻嗪)苯甲酰胺止吐剂,可中枢作用阻断D2受体,从而通过阻断呕吐中心的呕吐冲动来抑制髓质化学感受器触发区[1]。 |
| 体内研究 | Trimethobenzamide的口服生物利用度为60%至100%。口服给药后约45分钟达到峰值;肌肉注射后约30分钟肌内(IM)给药[1]。 |
| 参考文献 |
[1]. Smith HS, et al. Dopamine receptor antagonists. Ann Palliat Med. 2012 Jul;1(2):137-42. |
| 密度 | 1.131g/cm3 |
|---|---|
| 沸点 | 506.9ºC at 760mmHg |
| 熔点 | 187.5-190° |
| 分子式 | C21H29ClN2O5 |
| 分子量 | 424.91800 |
| 精确质量 | 424.17600 |
| PSA | 69.26000 |
| LogP | 3.77570 |
| InChIKey | WIIZEEPFHXAUND-UHFFFAOYSA-N |
| SMILES | COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC.Cl |
| 储存条件 | 2-8°C |
| 计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:6 4.可旋转化学键数量:10 5.互变异构体数量:2 6.拓扑分子极性表面积69.3 7.重原子数量:29 8.表面电荷:0 9.复杂度:440 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2 |
| 符号 |
GHS07, GHS08 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H302-H317-H334 |
| 警示性声明 | P261-P280-P284-P301 + P312 + P330-P304 + P340-P342 + P311 |
| 风险声明 (欧洲) | 20/21/22 |
| 安全声明 (欧洲) | 36 |
| 危险品运输编码 | UN 2811 6.1/PG 2 |
| WGK德国 | 3 |
| 海关编码 | 2924299090 |
|
~%
盐酸三甲氧苯酰胺 554-92-7 |
| 文献:Organic Process Research and Development, , vol. 17, # 7 p. 981 - 984 |
|
~%
盐酸三甲氧苯酰胺 554-92-7 |
| 文献:Organic Process Research and Development, , vol. 17, # 7 p. 981 - 984 |
|
~%
盐酸三甲氧苯酰胺 554-92-7 |
| 文献:Organic Process Research and Development, , vol. 17, # 7 p. 981 - 984 |
|
~%
盐酸三甲氧苯酰胺 554-92-7 |
| 文献:Neelakandan; Manikandan; Santosha; Prabhakaran Organic Process Research and Development, 2013 , vol. 17, # 7 p. 981 - 984 |
| 海关编码 | 2924299090 |
|---|---|
| 中文概述 | 2924299090. 其他环酰胺(包括环氨基甲酸酯)(包括其衍生物以及他们的盐). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途, 包装 |
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
实验名称:Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
来源:NCGC
External Id:SNCA-p-activity-luciferase
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: lu...
来源:824
External Id:CYP273
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify pos...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity
来源:NCGC
External Id:HERG01
|
|
实验名称:uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay
来源:Burnham Center for Chemical Genomics
靶标:cystic fibrosis transmembrane conductance regulator [Homo sapiens]
External Id:SBCCG-A764-CF-PAF-Primary-Assay
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ant...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_ANT_FLUO8_1536_1X%INH PRUN
|
|
实验名称:Primary qHTS for inhibitors of NSP2Pro chikungunya virus (CHIKV)
来源:NCGC
External Id:APP-Toga-CHIKV-nsp2-p
|
| Ametik hydrochloride |
| Trimethobenzamide hydrochloride |
| 3,4,5-trimethoxy-benzoic acid-[4-(2-dimethylamino-ethoxy)-benzylamide],hydrochloride |
| Trimethobenzamide HCL |
| Ibikin |
| UNII-WDQ5P1SX7Q |
| EINECS 209-075-6 |
| Tigan |
| 3,4,5-Trimethoxy-benzoesaeure-[4-(2-dimethylamino-aethoxy)-benzylamid],Hydrochlorid |
| N-(4-(2-(Dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide hydrochloride |
| Poligerim |
| Anaus |
| N-[p-[(2-dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxybenzamide hydrochloride |
| Nauseton |
| trimethoxybenzamide hydrochloride |
| trimethobenzamide chlorohydrate |